Skip to content

Assessing the Added Value of Adaptive Optics Ophthalmoscopy in Glaucoma Management: A Pilot Study

Assessing the Added Value of Adaptive Optics Ophthalmoscopy in Glaucoma Management: A Pilot Study - AO-FIO in Glaucoma Management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57430
Enrollment
40
Registered
2024-12-18
Start date
2026-05-26
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary open angle glaucoma high eye pressure

Interventions

None listed

Sponsors

Het Oogziekenhuis Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Glaucoma patients - Diagnosis of Primary Open-Angle Glaucoma (POAG) at the Rotterdam Eye Hospital. Healthy controls - Age-matched with glaucoma subjects.

Exclusion criteria

Exclusion criteria: A potential glaucoma subject who meets any of the following criteria will be excluded from the study: 1. History of diseases associated to retinal vascular effects (e.g. diabetes, high blood pressure, cardiovascular disease, ocular inflammation, retinal degeneration); 2. Smoking at least weekly within the last 5 years; 3. Any ocular abnormalities likely to interfere with scans (e.g., retinal abnormalities, corneal opacities, moderate to severe cataract, nystagmus); 4. Unable to give informed consent, including age

Design outcomes

Primary

MeasureTime frame
The Inner diameter, outer diameter, parietal thickness, wall cross-sectional area, and wall-to-lumen ratio (WLR); comparison between glaucoma patients and healthy controls.

Countries

Netherlands

Contacts

Public ContactV.J.A. Bourgonje

Het Oogziekenhuis Rotterdam

roi@oogziekenhuis.nl010 402 3449

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 25, 2026